CEMPRA INC's ticker is CEMP and the CUSIP is 15130J109. A total of 74 filers reported holding CEMPRA INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $326,000 | -43.1% | 100,054 | -19.7% | 0.00% | – |
Q2 2017 | $573,000 | -21.1% | 124,632 | -35.6% | 0.00% | – |
Q1 2017 | $726,000 | +10.7% | 193,662 | -17.3% | 0.00% | – |
Q4 2016 | $656,000 | -97.2% | 234,063 | -76.1% | 0.00% | -100.0% |
Q3 2016 | $23,692,000 | +62.7% | 978,961 | +10.8% | 0.01% | +40.0% |
Q2 2016 | $14,565,000 | -26.7% | 883,355 | -22.1% | 0.01% | -16.7% |
Q1 2016 | $19,859,000 | -65.8% | 1,133,467 | -39.2% | 0.01% | -66.7% |
Q4 2015 | $58,021,000 | +65.0% | 1,863,812 | +47.5% | 0.02% | +50.0% |
Q3 2015 | $35,169,000 | +89.8% | 1,263,220 | +134.3% | 0.01% | +140.0% |
Q2 2015 | $18,525,000 | -16.2% | 539,164 | -16.3% | 0.01% | -28.6% |
Q1 2015 | $22,103,000 | +26.8% | 644,195 | -13.1% | 0.01% | +16.7% |
Q4 2014 | $17,431,000 | +119.0% | 741,410 | +2.1% | 0.01% | +100.0% |
Q3 2014 | $7,958,000 | +4694.0% | 726,117 | +4937.9% | 0.00% | – |
Q1 2014 | $166,000 | -48.6% | 14,413 | -44.6% | 0.00% | – |
Q4 2013 | $323,000 | +118.2% | 26,035 | +102.0% | 0.00% | – |
Q3 2013 | $148,000 | – | 12,888 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 2,193,060 | $68,270,000 | 11.77% |
Abingworth LLP | 383,935 | $11,948,000 | 7.21% |
ACUTA CAPITAL PARTNERS, LLC | 250,000 | $7,783,000 | 3.72% |
Opaleye Management Inc. | 200,000 | $6,226,000 | 2.60% |
Knoll Capital Management, LLC | 180,800 | $5,628,000 | 2.09% |
Palo Alto Investors LP | 1,175,733 | $36,601,000 | 2.04% |
BB BIOTECH AG | 1,991,900 | $62,008,000 | 1.75% |
AlpInvest Partners B.V. | 31,400 | $977,000 | 1.62% |
GENERAL AMERICAN INVESTORS CO INC | 494,409 | $15,391,000 | 1.41% |
HARVEY CAPITAL MANAGEMENT INC | 112,250 | $3,494,000 | 1.38% |